Progressive bone deficit in epilepsy
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Chronic treatment with antiepileptic medication is associated with reduced bone mineral density (BMD), which may underlie the two- to sixfold increase in fracture rates observed in patients with epilepsy. The objective was to determine the timing of the BMD deficit in ambulatory children with epilepsy. METHODS: A cross-sectional evaluation was conducted in 82 ambulatory children aged 6 to 18 years (12.4 +/- 3.3 years) with epilepsy for <1 year (n = 18), 1 to 5 years (n = 37), and 6 or more years (n = 27). Controls were 32 healthy children aged 12.8 +/- 2.6 years. Age- and sex-corrected total body BMD Z-score was measured. RESULTS: Total BMD Z-score was lower in children with epilepsy (0.10 +/- 0.96; CI = -0.08, 0.34) compared to controls (0.57 +/- 0.74; CI = 0.3, 0.84; p = 0.03). Increasing duration of epilepsy was associated with a progressive reduction in BMD compared to controls (Spearman r = -0.197; p = 0.03). Compared to controls, those with epilepsy for 1 to 5 years had a mean BMD Z-score of 0.13 +/- 0.78 (CI = -0.13, 0.39; p = 0.04) and in those treated for 6 or more years BMD was 0.06 +/- 1.11 (CI = -0.38, 0.5; p = 0.04). For those with epilepsy for <1 year BMD was 0.23 +/- 1.1 (CI = -0.31, 0.77; p = 0.21). CONCLUSIONS: Children treated for epilepsy sustain significant bone mineral density (BMD) deficit compared to controls during the initial 1 to 5 years of treatment which progressively worsens thereafter. This progressive BMD deficit may be a contributing factor to the increased fracture risk observed in patients with epilepsy and may accelerate aging-related osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antiepileptic drugs interact with folate and vitamin B12 serum levels
Linnebank, M., Moskau, S., Semmler, A., Widman, G., Stoffel‐Wagner, B., Weller, M., & Elger, C. E. (2011) · Annals of Neurology · doi:10.1002/ana.22229 · Cited by 159
Bone density in peripubertal boys with Autism Spectrum Disorders
Neumeyer, A. M., Gates, A., Ferrone, C., Lee, H., & Misra, M. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1709-3 · Cited by 91
“Children with ASD have high rates of co-morbid neurologic and psychiatric illnesses, including epilepsy and mood disorders, which may be associated with increased cortisol levels, exacerbating the risk for low bone density (Greaves-Lord et al. 2009; Lopez-Duran et al. 2009; Sheth et al. 2008).”
BackgroundMenon, B., & Harinarayan, C. V. (2010) · Seizure · doi:10.1016/j.seizure.2010.01.006 · Cited by 70
The effect of the ketogenic diet on the developing skeleton
Simm, P. J., Bicknell-Royle, J., Lawrie, J., Nation, J., Draffin, K., Stewart, K. G., Cameron, F. J., Scheffer, I. E., & Mackay, M. T. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.07.014 · Cited by 67
“It is recognized that anti epileptic drug (AED) use is associated with lower bone mineral density (BMD) in both adults and children (Sheth et al., 1995; Petty et al., 2005; Babayigit et al., 2006; Sheth et al., 2008).”
Background
Metadata
- Authors
- Sheth, R. D., Binkley, N., & Hermann, B. P.
- Venue
- Neurology
- Published
- 2008-01-15
- Volume
- 70
- Issue
- 3
- Pages
- 170-176
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2127269744
- Cited by
- 85
- References
- 0
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progressive bone deficit in epilepsy. https://app.cochat.ai/papers/10.1212/01.wnl.0000284595.45880.93
- The paper
- Sheth, R. D., Binkley, N., & Hermann, B. P. (2008). Progressive bone deficit in epilepsy. Neurology. https://doi.org/10.1212/01.wnl.0000284595.45880.93
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.